NVAX
NASDAQ · Biotechnology
Novavax Inc
$9.53
-0.55 (-5.46%)
Open$10.11
Previous Close$10.08
Day High$10.38
Day Low$9.49
52W High$13.39
52W Low$6.20
Volume—
Avg Volume4.95M
Market Cap1.61B
P/E Ratio—
EPS$-1.54
SectorBiotechnology
Analyst Ratings
Buy
15 analysts
Price Target
+203.0% upside
Current
$9.53
$9.53
Target
$28.88
$28.88
$20.35
$28.88 avg
$29.25
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.10B | 1.33B | 441.16M |
| Net Income | 430.56M | 468.23M | -6,729,988 |
| Profit Margin | 39.2% | 37.2% | -1.5% |
| EBITDA | 441.70M | 507.03M | -8,036,743 |
| Free Cash Flow | — | — | -9,195,591 |
| Rev Growth | -17.2% | -17.2% | +6.7% |
| Debt/Equity | 0.75 | 0.75 | 0.98 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |